Investigational A₃ adenosine receptor targeting agents

Author： Koscsó Balázs Csóka Balázs Pacher Pál Haskó György

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.6, 2011-06, pp. : 757-768

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenosine receptor targeting in health and disease

By Gessi Stefania Merighi Stefania Fazzi Debora Stefanelli Angela Varani Katia Borea Pier Andrea

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1591-1609

Informa Healthcare

Access to resources Recommend Favorite

A3 Adenosine Receptor Antagonists

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 4, 2001-11 ,pp. : 417-427

Bentham Science Publishers

Access to resources Recommend Favorite

Investigational drugs for schizophrenia targeting the dopamine receptor: Phase II trials

By Rao Naren P Remington Gary

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 7, 2013-11 ,pp. : 881-894

Informa Healthcare

Access to resources Recommend Favorite

Adenosine and the Nervous System - the A3 adenosine receptor

By Guieu R. Dussol B. Rochat H. Couraud F. Rochat H. Halimi G. Bechis G. Sampieri F. Berland Y. Rochat H. Couraud F. Rochat H. Sampol J. Rochat H. Couraud F. Rochat H. Couraud F. Rochat H.

General Pharmacology, Vol. 31, Iss. 4, 1998-10 ,pp. : 553-561

Elsevier

Access to resources Recommend Favorite

Adenosine Receptor Agents and Conditioned Place Preference

By Zarrindast M.R. Moghadamnia A.A.

General Pharmacology, Vol. 29, Iss. 2, 1997-08 ,pp. : 285-289

Elsevier

Access to resources Recommend Favorite